At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
As a leader in cardiovascular research for more than 60 years, we have been a trailblazer in the fight against cardiovascular disease and have pioneered the science behind many game-changing targets. Over the years, we have made a meaningful difference in the lives of millions of people around the world. However, despite these many advances, cardiovascular disease continues to be the leading cause of death globally. We are determined to fundamentally change how we approach prevention and treatment of cardiovascular disease in the future – focusing our efforts on disease-modifying medicines that help patients living with arterial thrombosis, defined sets of heart failure and heritable cardiomyopathies, in ways that were never possible before.
